<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02097784</url>
  </required_header>
  <id_info>
    <org_study_id>2013.831</org_study_id>
    <nct_id>NCT02097784</nct_id>
  </id_info>
  <brief_title>Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury</brief_title>
  <official_title>Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study focuses on the interest of the echocardiography for cirrhotic
      patients, who present acute kidney injury corresponding to the criteria of hepatorenal
      syndrome. This echocardiography will be done before the volemic expansion and the final
      diagnostic of hepatorenal syndrome or prerenal azotemia. The primary endpoint is to describe
      the hemodynamic characteristics of this population at the time of acute kidney injury and
      their association with diagnostic of hepatorenal syndrome or prerenal azotemia. Patients with
      elevated filling pressure, predicting poor outcome of volemic expansion will be excluded of
      the study after the echocardiography and will not undergo volemic expansion but appropriate
      management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemodynamic features assessed by echocardiography before the volemic expansion of cirrhotic patients with acute renal injury corresponding to the criteria of hepatorenal syndrome.</measure>
    <time_frame>At Day0 : at the time of diagnostic of acute kidney injury, before volemic expansion.</time_frame>
    <description>Systolic and diastolic function assessment, filling pressures, pulmonary arterial hypertension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance of volemic expansion, as recommended by international guidelines</measure>
    <time_frame>After 48 hours of volemic expansion</time_frame>
    <description>Clinical tolerance of volemic expansion, acute pulmonary oedema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response to vasoconstrictor treatment of hepatorenal syndrome, in case of diagnostic of hepatorenal syndrome</measure>
    <time_frame>1 month after inclusion</time_frame>
    <description>Renal function recovery, renal replacement therapy, liver transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 month after inclusion</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hepatorenal Syndrome</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Diastolic Function</condition>
  <arm_group>
    <arm_group_label>cirrhosis with portal hypertension,ascite and acute kidney</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <arm_group_label>cirrhosis with portal hypertension,ascite and acute kidney</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients &gt; 18 years

          -  written consent for the participation of the study

          -  cirrhosis with portal hypertension and ascite

          -  acute kidney injury according to AKIN criteria (rapid increase of creatinine (48
             hours) &gt; 26.4 µmol or &gt; 50% comparing with baseline). Baseline creatinine is the last
             value of creatinine before admission or creatinine at the admission if stable during 5
             days.

          -  absence of argument for acute tubular necrosis or other organic acute renal injury

          -  absence of argument for shock

        Exclusion Criteria:

          -  pregnant women

          -  volemic expansion before echocardiography

          -  portal thrombosis

          -  presence of TIPSS

          -  history of cardiac or renal pathology

          -  atrial fibrillation

          -  cardiac valvulopathy

          -  technical limitation due to echogenicity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fanny LEBOSSE, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fanny LEBOSSE, Dr</last_name>
    <email>fanny.lebosse@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sylvie THEVENON</last_name>
    <email>sylvie.thevenon01@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hôpital de la Croix-Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny Lebosse, Dr</last_name>
      <email>fanny.lebosse@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sylvie Thevenon</last_name>
      <phone>4 26 73 27 28</phone>
      <phone_ext>+33</phone_ext>
      <email>sylvie.thevenon01@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Fanny LEBOSSE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2014</study_first_submitted>
  <study_first_submitted_qc>March 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2014</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cirrhosis</keyword>
  <keyword>hepatorenal syndrome</keyword>
  <keyword>acute kidney injury</keyword>
  <keyword>diastolic function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Hepatorenal Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

